Ubiquitin Like Protein ISG15 Conjugation
泛素样蛋白 ISG15 缀合
基本信息
- 批准号:6687384
- 负责人:
- 金额:$ 40.36万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-07-01 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:cell line clinical research cytokine gene targeting human tissue immunoaffinity chromatography laboratory mouse ligase liquid chromatography mass spectrometry matrix assisted laser desorption ionization phosphorylation posttranslational modifications protein purification protein structure function ubiquitin
项目摘要
DESCRIPTION (provided by applicant):
The long-term goal of this study is to understand the biological function of protein modification by the ubiquitin like protein ISG15. In recent years our knowledge of protein ubiquitination has expanded rapidly and as a consequence protein ubiquitination has been found to play important roles in various aspects of cellular functions, including cell cycle, membrane receptor signal transduction, endocytosis, and DNA repair. In contrast, little is known about the role of protein modification by ISG15. We cloned a novel member of the deubiquitinating enzyme family, termed UBP43. Further studies have demonstrated that UBP43 is a protease that specifically removes ISG15 from its conjugates. Type I interferon (INFa/b) and LPS strongly upregulate both UBP43 expression and protein ISGylation. We have generated UBP43 knockout mice. UBP43 deficient mice show fundamental defects in development and in response to interferon and LPS treatment. This proposal will test the hypothesis that protein ISG15 modification plays a fundamental role in maintaining cellular metabolism under conditions of stress. The studies proposed in Specific Aim#1 will identify the molecular targets of ISG15. We have established an immuno-affinity purification method for such an approach. The studies proposed in Specific Aim #2 will characterize the function of protein ISGylation by defining ISG15 modification sites in target proteins and studying the effect of ISGylation on target proteins. We have identified several ISGylated proteins. The studies proposed in Specific Aim #3 will generate conditional ISG15 activating enzyme UBE1L knockout mice to analyze the function of protein ISGylation. The experiments proposed will address important questions about protein ISGylation and may provide valuable insights into the therapeutic treatment of human diseases, such as viral infection and cancer.
描述(由申请人提供):
本研究的长期目标是了解泛素样蛋白ISG15修饰蛋白质的生物学功能。近年来,我们对蛋白质泛素化的认识迅速扩大,因此蛋白质泛素化被发现在细胞周期、膜受体信号转导、内吞作用和DNA修复等细胞功能的各个方面发挥着重要作用。相比之下,人们对ISG15蛋白修饰的作用知之甚少。我们克隆了去泛素酶家族的一个新成员,命名为UBP43。进一步的研究表明,UBP43是一种能特异性地将ISG15从其结合物中移除的蛋白酶。I型干扰素(INFA/b)和脂多糖强烈上调UBP43的表达和蛋白ISG化。我们已经产生了UBP43基因敲除小鼠。UBP43缺陷小鼠在发育和对干扰素和内毒素治疗的反应中表现出根本的缺陷。这一提议将检验这样一种假设,即蛋白质ISG15修饰在维持应激条件下细胞新陈代谢方面发挥着基础性作用。在特殊目标#1中提出的研究将确定ISG15的分子靶标。我们已经为这种方法建立了一种免疫亲和纯化方法。在特殊目的#2中提出的研究将通过定义目标蛋白中的ISG15修饰位点并研究ISG化对目标蛋白的影响来表征蛋白质ISG化的功能。我们已经鉴定了几种ISGylated蛋白。在特殊目的#3中提出的研究将产生条件性ISG15激活酶UBE1L基因敲除小鼠,以分析蛋白质ISG化的功能。提出的实验将解决有关蛋白质ISG化的重要问题,并可能为病毒感染和癌症等人类疾病的治疗提供有价值的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DONG-ER ZHANG其他文献
DONG-ER ZHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DONG-ER ZHANG', 18)}}的其他基金
CSF2 receptor mediated actions in t(8;21) leukemia
CSF2 受体介导的 t(8;21) 白血病作用
- 批准号:
9014529 - 财政年份:2015
- 资助金额:
$ 40.36万 - 项目类别:
CSF2 receptor mediated actions in t(8;21) leukemia
CSF2 受体介导的 t(8;21) 白血病作用
- 批准号:
8842430 - 财政年份:2015
- 资助金额:
$ 40.36万 - 项目类别:
Synergestic roles of SRF2 and RUNX1 in blood cell development and pathology
SRF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
10400021 - 财政年份:2013
- 资助金额:
$ 40.36万 - 项目类别:
ISG15 and protein ISGylation in Cancer
癌症中的 ISG15 和蛋白质 ISGylation
- 批准号:
8616739 - 财政年份:2013
- 资助金额:
$ 40.36万 - 项目类别:
ISG15 and protein ISGylation in Cancer
癌症中的 ISG15 和蛋白质 ISGylation
- 批准号:
8535417 - 财政年份:2013
- 资助金额:
$ 40.36万 - 项目类别:
Synergestic roles of SRF2 and RUNX1 in blood cell development and pathology
SRF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
9922899 - 财政年份:2013
- 资助金额:
$ 40.36万 - 项目类别:
相似海外基金
FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
- 批准号:
EP/Y036395/1 - 财政年份:2024
- 资助金额:
$ 40.36万 - 项目类别:
Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
- 批准号:
10764456 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
- 批准号:
10715568 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
- 批准号:
10743328 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
- 批准号:
10638813 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
- 批准号:
10823828 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
- 批准号:
10828665 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
- 批准号:
10721095 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
- 批准号:
10795328 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
- 批准号:
10828252 - 财政年份:2023
- 资助金额:
$ 40.36万 - 项目类别: